when will tirzepatide be available in canada Weight-loss drug approved to treat sleep apnea Episode 153. All About Zepbound

10.1371/journal.pmed.1000097 37 NIHR (2025)

Metabolic-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) studies: Studied in adults with moderate-to-advanced liver fibrosis resulting from chronic fat accumulation and inflammation

This approach reduced the potential for confounding factors that could bias the results, such as differences in individual health status or baseline risk

TGA concluded that a reduced effectiveness of oral contraceptives could not be ruled out, and added the following precaution: Patients using oral contraceptives should switch to a non-oral method or add a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase